Moleculin Announces COVID-19 In Vivo Testing Contracted for WP1122
- Monday, September 14, 2020, 7:10
- PR Newswire
- Add a comment
HOUSTON, Sept. 14, 2020 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that it has contracted with an…
About the Author
admin has written 20652 stories on this site.